… In 2009, the American Society for Blood and Marrow Transplantation Steering Committee …
(based on donor availability) and showed significantly better relapse-free survival (RFS) for …

… At 30 days post-transplant full donor chimerism was … in OS, progression-free survival (PFS),
relapse incidence or NRM … for International Blood and Marrow Transplant Research tried to …

… statistically significant predictor for NRM and relapse, possibly … was linked with markedly
increased relapse-free survival in … + 90 after HSCT, donor chimerism was assessed. If clinically …

… bulk of the disease; this score is still the most powerful predictor of … therapy was able to
restore full donor chimerism in 57% patients.… before allogeneic blood or marrow transplantation. …

… More recently, murine models of bone marrow transplantation … relapse/progression or when
no acceptably matched donor … Chimerism and immune reconstitution analyses are shown …

… of relapse, disease free survival (DFS) and overall survival (… acute myeloid leukemia (AML),
acute lymphoblastic leukemia (… (primary graft failure), or loss of donor chimerism after initial …

… of patients with relapsed chronic myeloid leukemia 7, 8. Singhal … Disease-free survival (DFS)
was defined as the survival … Analysis of chimerism indicated that full donor chimerism was …

… Bone marrow transplantation … significantly improved overall survival (OS) and relapse-free
survival (RFS) … to HCT with the best available donor in first complete remission (CR1) (grade …

… profile is the most important predictor of disease recurrence … event-free survival and overall
survival benefit compared with … with complete donor haemopoietic chimerism were observed. …

… -year overall survival (OS), 3-year progression-free survival (PFS… /aplastic bone marrow;
and complete donor chimerism … donor options and for whom the indication for allogenic …